Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Alfizah Hanafiah"'
Autor:
Alfizah Hanafiah, Bruno S. Lopes
Publikováno v:
Pharmaceuticals, Vol 17, Iss 9, p 1122 (2024)
Antibiotic resistance in Gram-negative bacteria is a formidable challenge in modern medicine [...]
Externí odkaz:
https://doaj.org/article/0f3493e9f04f463388197aab7c378555
Autor:
Alfizah Hanafiah, Siti Nur Arifah Abd Aziz, Zarith Nameyrra Md Nesran, Xavier Chee Wezen, Mohd Fadzli Ahmad
Publikováno v:
Heliyon, Vol 10, Iss 6, Pp e28128- (2024)
The impact of H. pylori resistance on patient's treatment failure is a major concern. Therefore, the development of novel or alternative therapies for H. pylori is urgently needed. The purpose of this study was to investigate the molecular interactio
Externí odkaz:
https://doaj.org/article/b20551213d6946d3801d1435b05f97ee
Publikováno v:
Emerging Science Journal, Vol 7, Iss 5, Pp 1797-1810 (2023)
Despite a plethora of research on vaccine developments and the adverse effects of the vaccineworldwide, there are several research studies on COVID-19 vaccine hesitancy or rejection. The objectives of this study were to investigate the impact of the
Externí odkaz:
https://doaj.org/article/607fdde968ea402c9f2e7239059d7f3d
Autor:
Alfizah Hanafiah, Asif Sukri, Hamidah Yusoff, Chia Sing Chan, Nur Hazlin Hazrin-Chong, Sharifah Azura Salleh, Hui-min Neoh
Publikováno v:
Antibiotics, Vol 13, Iss 2, p 127 (2024)
Hospital environmental surfaces are potential reservoirs for transmitting hospital-associated pathogens. This study aimed to profile microbiomes and antibiotic resistance genes (ARGs) from hospital environmental surfaces using 16S rRNA amplicon and m
Externí odkaz:
https://doaj.org/article/64203486091848e189288646cdba97a6
Autor:
Aswini Kumareswaran, Sophia Ogechi Ekeuku, Norazlina Mohamed, Norliza Muhammad, Alfizah Hanafiah, Kok-Lun Pang, Sok Kuan Wong, Deborah Chia Hsin Chew, Kok-Yong Chin
Publikováno v:
Life, Vol 13, Iss 9, p 1882 (2023)
Gut dysbiosis has been associated with many chronic diseases, such as obesity, inflammatory bowel disease, and cancer. Gut dysbiosis triggers these diseases through the activation of the immune system by the endotoxins produced by gut microbiota, whi
Externí odkaz:
https://doaj.org/article/9bf8827824a644f3863e5eb70029a76e
Publikováno v:
Pharmaceuticals, Vol 16, Iss 4, p 552 (2023)
Alternative therapies and vaccination are essential to combat the emergence of multidrug-resistant Helicobacter pylori and to prevent the development of gastroduodenal diseases. This review aimed to systematically review recent studies on alternative
Externí odkaz:
https://doaj.org/article/89d21c2004484525af80bd0f4669fec5
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 24, Iss 6, Pp 545-551 (2020)
Background: Helicobacter pylori harbouring cag-pathogenicity island (cagPAI) which encodes type IV secretion system (T4SS) and cagA virulence gene are involved in inflammation of the gastric mucosa. We examined all the 27 cagPAI genes in 88 H. pylori
Externí odkaz:
https://doaj.org/article/c1f4c416db1848a68d442958417d0c58
Autor:
Asif Sukri, Alfizah Hanafiah, Hamidah Yusoff, Nur Atiqah Shamsul Nizam, Zarith Nameyrra, Zhiqin Wong, Raja Affendi Raja Ali
Publikováno v:
Antibiotics, Vol 11, Iss 10, p 1391 (2022)
Background: The emergence of multidrug-resistant Helicobacter pylori has undermined eradication strategies to prevent the development of gastric cancer. This study was conducted to estimate the prevalence of secondary antibiotic resistance of H. pylo
Externí odkaz:
https://doaj.org/article/42ae295a8cfc4dfbb83741bda92bdd21
Autor:
Bruno S. Lopes, Alfizah Hanafiah, Ramesh Nachimuthu, Saravanan Muthupandian, Zarith Nameyrra Md Nesran, Sandip Patil
Publikováno v:
Molecules, Vol 27, Iss 9, p 2995 (2022)
Just over a million people died globally in 2019 due to antibiotic resistance caused by ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species).
Externí odkaz:
https://doaj.org/article/a2ef423713e84d039f54146241960a7e
Publikováno v:
Antibiotics, Vol 10, Iss 9, p 1061 (2021)
The emergence of multidrug-resistant H. pylori poses a public healthcare threat, particularly in low- and middle-income countries. Recently, the World Health Organization has classified clarithromycin-resistant H. pylori as high priority in the resea
Externí odkaz:
https://doaj.org/article/13efbc78b3f44c068b86024f01400c88